LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Apogee Therapeutics Announces Positive Interim Results From Phase 1b Trial Of Zumilokibart In Mild-to-moderate Asthma 1/6/2026 6:08:17 AM
  • Apogee Therapeutics Reports Positive Phase 1 Data For APG333, Supporting Long-Interval Dosing And Strong Tolerability 11/10/2025 7:58:23 AM
  • Apogee Therapeutics Prices $300 Mln Public Offering Of Common Stock And Pre-Funded Warrants 10/8/2025 10:10:06 PM
  • Wedbush Is Lowering Apogee Therapeutics, Inc. (APGE) FY 26 Estimate To -4.75 From -4.07 8/11/2025 5:39:59 PM
  • Wedbush Is Lowering Apogee Therapeutics, Inc. (APGE) Q4 26 Estimate To -1.13 From -1.06 8/11/2025 5:39:47 PM
  • Wedbush Is Lowering Apogee Therapeutics, Inc. (APGE) Q3 26 Estimate To -1.18 From -1.03 8/11/2025 5:39:36 PM
  • Wedbush Is Lowering Apogee Therapeutics, Inc. (APGE) Q2 26 Estimate To -1.18 From -1.01 8/11/2025 5:39:23 PM
  • Wedbush Is Cutting Apogee Therapeutics, Inc. (APGE) Q1 26 Estimate To -1.27 From -0.98 8/11/2025 5:39:11 PM
  • Wedbush Is Cutting Apogee Therapeutics, Inc. (APGE) FY 25 Estimate To -4.53 From -3.89 8/11/2025 5:38:57 PM
  • Wedbush Is Lowering Apogee Therapeutics, Inc. (APGE) Q4 25 Estimate To -1.24 From -0.96 8/11/2025 5:38:37 PM
  • Wedbush Is Cutting Apogee Therapeutics, Inc. (APGE) Q3 25 Estimate To -1.21 From -0.96 8/11/2025 5:38:28 PM
  • Wedbush Reiterates Apogee Therapeutics, Inc. (APGE) At Outperform With $90 Price Target 8/11/2025 5:38:00 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap